We are live on ! Find out more
HP

HT Partners Portfolio holdings

AUM $361M
1-Year Est. Return 22.6%
This Fund
S&P 500
This Quarter Est. Return
+3.95%
1 Year Est. Return
+22.6%
3 Year Est. Return
+63.11%
5 Year Est. Return
+51.89%
10 Year Est. Return
+146.71%
AUM
$347M
AUM Growth
+$8.68M
Cap. Flow
-$3.62M
Cap. Flow %
-1.04%
Top 10 Hldgs %
86.34%
Holding
54
New
2
Increased
8
Reduced
24
Closed
3

Sector Composition

Rank Sector Weight
1 Miscellaneous 93.89%
2 Technology 1.92%
3 Healthcare 1.42%
4 Consumer Staples 0.94%
5 Communication Services 0.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDS icon
51
CALL
ProShares UltraShort S&P500
SDS
$385M
$20.6K 0.01%
+4,000
New +$769K
ACHC icon
52
Acadia Healthcare
ACHC
$2.62B
-2,893
Closed -$209K
EUO icon
53
CALL
ProShares UltraShort Euro
EUO
$32.9M
-10,000
Closed -$8K
VZ icon
54
Verizon
VZ
$208B
-5,306
Closed -$206K

Similar funds

HT Partners's Q2 2023 Portfolio in Review

As of Q2 2023, HT Partners held 54 positions worth $347M, up 2.6% from $339M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

HT Partners's Q2 2023 filing shows 2 new, 8 increased, 24 reduced and 3 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 468 shares worth $209K. The largest sale was Clorox, an estimated $2.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 94% a quarter earlier, followed by Technology and Healthcare.

  • HT Partners's largest Q2 2023 buy was iShares Core S&P 500 ETF: 468 shares worth $209K.
  • HT Partners added most to Meta Platforms (Facebook) in Q2 2023, an estimated $92.8K increase.
  • HT Partners's biggest Q2 2023 reduction was Clorox, cutting an estimated $2.6M.
  • HT Partners fully exited Acadia Healthcare in Q2 2023, selling an estimated $209K.
  • HT Partners's ten largest holdings make up 86% of its $347M portfolio in Q2 2023.
  • HT Partners opened 2 new positions and closed 3 in Q2 2023.
  • HT Partners's portfolio value rose 2.6% quarter-over-quarter to $347M.

Based on HT Partners's 13F filing for Q2 2023, filed 12 Jul 2023.